Synopsis
Synopsis
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 4-(ethyl-(4-methoxy-alpha-methylphenethyl)aminobutyl) Veratrate
2. Duspatalin
3. Mebeverine
4. Spasmotalin
1. 2753-45-9
2. Mebeverine Hcl
3. Duspatalin
4. Colofac
5. Csag-144
6. Csag 144
7. Mebeverine Hydrochloride [usan]
8. Mebeverine (hydrochloride)
9. Nsc-169101
10. 15vz5al4jn
11. 4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl 3,4-dimethoxybenzoate;hydrochloride
12. Mls000028652
13. Duspatal
14. Benzoic Acid, 3,4-dimethoxy-, 4-(ethyl(2-(4-methoxyphenyl)-1-methylethyl)amino)butyl Ester, Hydrochloride
15. Rudakol
16. Smr000058862
17. Dsstox_cid_25372
18. Dsstox_rid_80834
19. Dsstox_gsid_45372
20. Mebeverine Hydrochloride (usan)
21. 4-(ethyl(1-(4-methoxyphenyl)propan-2-yl)amino)butyl 3,4-dimethoxybenzoate Hydrochloride
22. 4-{ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino}butyl 3,4-dimethoxybenzoate Hydrochloride
23. Nsc 169101
24. Nsc169101
25. Einecs 220-400-0
26. Unii-15vz5al4jn
27. Sr-01000003159
28. 4-(ethyl(p-methoxy-.alpha.-methylphenethyl)amino)butyl Veratrate Hydrochloride
29. 4-[ethyl(p-methoxy-.alpha.-methylphenethyl)amino]butyl Veratrate Hydrochloride
30. Prestwick_587
31. Mebeverine D6 Hcl
32. Colofac Hydrochloride
33. Duspatal Hydrochloride
34. Duspatalin Hydrochloride
35. Opera_id_1589
36. Ncgc00016617-01
37. 4-(ethyl(p-methoxy-alpha-methylphenethyl)amino)butyl Veratrate Hydrochloride
38. Cas-2753-45-9
39. Mls001148590
40. Mls002222299
41. Schembl121977
42. Spectrum1501117
43. Regid_for_cid_17683
44. Chembl1446650
45. Dtxsid1045372
46. Hms1568n22
47. Hms1921f15
48. Pharmakon1600-01501117
49. Bcp28149
50. Ex-a4568
51. Hy-a0078
52. Tox21_110527
53. Ccg-39022
54. Mebeverine Hydrochloride [mi]
55. Mfcd00083411
56. Nsc757840
57. S5027
58. Akos027420570
59. Tox21_110527_1
60. Cs-6931
61. Nsc-757840
62. 4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl 3,4-dimethoxybenzoate Hydrochloride
63. Mebeverine Hydrochloride [mart.]
64. Veratric Acid, 4-(ethyl(p-methoxy-alpha-methylphenethyl)amino)butyl Ester, Hydrochloride
65. Mebeverine Hydrochloride [who-dd]
66. Ncgc00018277-06
67. Ncgc00094900-01
68. Ncgc00094900-02
69. Ncgc00094900-03
70. 3,4-dimethoxybenzoic Acid 4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino]butyl Ester Hydrochloride
71. Veratric Acid, Butyl Ester, Hydrochloride
72. Db-047240
73. Ft-0603620
74. Mebeverine Hydrochloride, Analytical Standard
75. D04868
76. Mebeverine Hydrochloride [ep Monograph]
77. N16922
78. Wln: 1or Bo1 Dvo4n2&y1&1r Do1 &gh
79. 753m459
80. A819105
81. Sr-01000003159-4
82. W-109821
83. Mebeverine Hcl Pound>>csag-144 Pound>>csag 144 Pound>>csag144
84. 3,4-dimethoxybenzoicacid4-ethyl2-(4-methoxyphenyl)-1-methylethylaminobutylesterhydrochloride
85. 4-(ethyl(1-(4-methoxyphenyl)propan-2-yl)amino)butyl3,4-dimethoxybenzoatehydrochloride
86. Veratric Acid, 4-[ethyl(p-methoxy-.alpha.-methylphenethyl)amino]butyl Ester Hydrochloride
87. 3,4-dimethoxybenzoic Acid 4-[ethyl-[1-(4-methoxyphenyl)propan-2-yl]amino]butyl Ester Hydrochloride
88. Benzoic Acid,4-dimethoxy-, 4-[ethyl[2-(4-methoxyphenyl)-1-methylethyl]amino]butyl Ester, Hydrochloride
| Molecular Weight | 466.0 g/mol |
|---|---|
| Molecular Formula | C25H36ClNO5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 14 |
| Exact Mass | 465.2282009 g/mol |
| Monoisotopic Mass | 465.2282009 g/mol |
| Topological Polar Surface Area | 57.2 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 494 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
Anticonvulsants
Drugs used to prevent SEIZURES or reduce their severity. (See all compounds classified as Anticonvulsants.)
API SUPPLIERS
Synthokem Labs specializes in producing APIs and intermediates for the global pharma industry.
Certificate Number : CEP 2021-271 - Rev 00
Issue Date : 2023-09-25
Type : Chemical
Substance Number : 2097
Status : Valid
Date of Issue : 2022-06-29
Valid Till : 2025-07-14
Written Confirmation Number : WC-0358
Address of the Firm :
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Certificate Number : R0-CEP 2019-061 - Rev 02
Issue Date : 2022-12-15
Type : Chemical
Substance Number : 2097
Status : Valid
Date of Issue : 2022-07-07
Valid Till : 2025-07-21
Written Confirmation Number : WC-0150
Address of the Firm :
| Available Reg Filing : ASMF, CN, BR, RU, AU, TDMF |
Jai Radhe Sales is your partner for all your sourcing needs.
Moehs Group, a reference company in the production of pharmaceutical active ingredients.
HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.
Together we can improve the quality of life
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Date of Issue : 2022-07-07
Valid Till : 2025-07-21
Written Confirmation Number : WC-0150
Address of the Firm :
| Available Reg Filing : ASMF, CN, BR, RU, AU, TDMF |
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 8297
Submission : 1989-11-13
Status : Inactive
Type : II
Certificate Number : CEP 2022-002 - Rev 00
Issue Date : 2024-03-13
Type : Chemical
Substance Number : 2097
Status : Valid
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
INTERMEDIATE SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Europe
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Australia
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Global Sales Information
Regulatory FDF Prices
RX/OTC/DISCN : Class B
Dosage Form : Ret Caps
Dosage Strength : 200mg
Price Per Pack (Euro) : 7.38
Published in :
Country : Switzerland
RX/OTC/DISCN : Class B
RX/OTC/DISCN : Class B
Dosage Form : Ret Caps
Dosage Strength : 200mg
Price Per Pack (Euro) : 12.99
Published in :
Country : Switzerland
RX/OTC/DISCN : Class B
RX/OTC/DISCN : Class C
SOLVAY PHARMA SpA
Dosage Form :
Dosage Strength : 20 Cps 200 Mg Prolonged Release
Price Per Pack (Euro) : 14.54
Published in :
Country : Italy
RX/OTC/DISCN : Class C
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Market Place
APIs
Reply
04 Jul 2025
Reply
03 May 2025
Reply
19 Nov 2024
Reply
13 Nov 2024
Reply
31 Aug 2023
Reply
24 Feb 2023
Reply
22 Apr 2022
Reply
11 Jun 2021
Reply
02 Jun 2021
Reply
11 Mar 2021
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
FDF DOSSIERS
Reply
28 May 2025
Reply
12 Mar 2024
Reply
08 Apr 2022
Reply
09 Apr 2021
Reply
22 Mar 2021
Reply
28 Jan 2016
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
10
PharmaCompass offers a list of Mebeverine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mebeverine manufacturer or Mebeverine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mebeverine manufacturer or Mebeverine supplier.
PharmaCompass also assists you with knowing the Mebeverine API Price utilized in the formulation of products. Mebeverine API Price is not always fixed or binding as the Mebeverine Price is obtained through a variety of data sources. The Mebeverine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Mebeverine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mebeverine, including repackagers and relabelers. The FDA regulates Mebeverine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mebeverine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Mebeverine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Mebeverine supplier is an individual or a company that provides Mebeverine active pharmaceutical ingredient (API) or Mebeverine finished formulations upon request. The Mebeverine suppliers may include Mebeverine API manufacturers, exporters, distributors and traders.
click here to find a list of Mebeverine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mebeverine DMF (Drug Master File) is a document detailing the whole manufacturing process of Mebeverine active pharmaceutical ingredient (API) in detail. Different forms of Mebeverine DMFs exist exist since differing nations have different regulations, such as Mebeverine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mebeverine DMF submitted to regulatory agencies in the US is known as a USDMF. Mebeverine USDMF includes data on Mebeverine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mebeverine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mebeverine suppliers with USDMF on PharmaCompass.
A Mebeverine CEP of the European Pharmacopoeia monograph is often referred to as a Mebeverine Certificate of Suitability (COS). The purpose of a Mebeverine CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Mebeverine EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Mebeverine to their clients by showing that a Mebeverine CEP has been issued for it. The manufacturer submits a Mebeverine CEP (COS) as part of the market authorization procedure, and it takes on the role of a Mebeverine CEP holder for the record. Additionally, the data presented in the Mebeverine CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Mebeverine DMF.
A Mebeverine CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Mebeverine CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Mebeverine suppliers with CEP (COS) on PharmaCompass.
A Mebeverine written confirmation (Mebeverine WC) is an official document issued by a regulatory agency to a Mebeverine manufacturer, verifying that the manufacturing facility of a Mebeverine active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Mebeverine APIs or Mebeverine finished pharmaceutical products to another nation, regulatory agencies frequently require a Mebeverine WC (written confirmation) as part of the regulatory process.
click here to find a list of Mebeverine suppliers with Written Confirmation (WC) on PharmaCompass.
Mebeverine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mebeverine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mebeverine GMP manufacturer or Mebeverine GMP API supplier for your needs.
A Mebeverine CoA (Certificate of Analysis) is a formal document that attests to Mebeverine's compliance with Mebeverine specifications and serves as a tool for batch-level quality control.
Mebeverine CoA mostly includes findings from lab analyses of a specific batch. For each Mebeverine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mebeverine may be tested according to a variety of international standards, such as European Pharmacopoeia (Mebeverine EP), Mebeverine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mebeverine USP).
Comment (2)
